English
Insider transactions
EDGARKYMERA THERAPEUTICS, INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-18.
- Open-market purchases (code P)
- 2 transactions, 2,005,813 shares
- Sum of shares × price per share: 172,499,918
- Open-market sales (code S)
- 274 transactions, 4,560,526 shares
- Sum of shares × price per share: 473,286,847.7549
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 386
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-01 Filed 2026-10-01 | Mainolfi Nello Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 30,000 | 2.08 | 62,400Derived: shares × price per share. Exact value 62400.00. | 696,568 | Direct (D) | Yes | F1
| Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-01 | Mainolfi Nello Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,525 | 111.44 | 392,826Derived: shares × price per share. Exact value 392826.00. | 693,043 | Direct (D) | Yes | F1, F2
| Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-01 | Mainolfi Nello Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,506 | 112.42 | 618,984.52Derived: shares × price per share. Exact value 618984.52. | 687,537 | Direct (D) | Yes | F1, F3
| Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-01 | Mainolfi Nello Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,876 | 113.24 | 552,158.24Derived: shares × price per share. Exact value 552158.24. | 682,661 | Direct (D) | Yes | F1, F4
| Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-01 | Mainolfi Nello Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,601 | 114.43 | 869,782.43Derived: shares × price per share. Exact value 869782.43. | 675,060 | Direct (D) | Yes | F1, F5
| Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-01 | Mainolfi Nello Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 8,230 | 115.40 | 949,742Derived: shares × price per share. Exact value 949742.00. | 666,830 | Direct (D) | Yes | F1, F6
| Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-01 | Mainolfi Nello Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 262 | 116.12 | 30,423.44Derived: shares × price per share. Exact value 30423.44. | 666,568 | Direct (D) | Yes | F1, F7
| Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-01 | Mainolfi Nello Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 30,000 | 0 | — | 60,000 | Direct (D) | Yes | F1, F8
| Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row |
| 2026-09-04 Filed 2026-09-04 | Adams Brian Officer: Chief Legal Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,209 | 115.55 | 139,699.95Derived: shares × price per share. Exact value 139699.95. | 55,416 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-383874 Read from the filing’s XML Dispute this row |
| 2026-09-04 Filed 2026-09-04 | Adams Brian Officer: Chief Legal Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,025 | 116.81 | 353,350.25Derived: shares × price per share. Exact value 353350.25. | 52,391 | Direct (D) | No | F1, F3
| Open filing 0001193125-26-383874 Read from the filing’s XML Dispute this row |
| 2026-09-04 Filed 2026-09-04 | Adams Brian Officer: Chief Legal Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,137 | 117.57 | 251,247.09Derived: shares × price per share. Exact value 251247.09. | 50,254 | Direct (D) | No | F1, F4
| Open filing 0001193125-26-383874 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-27 | Rooney Terence Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 38,000 | 0 | — | 38,000 | Direct (D) | No | F1
| Open filing 0001193125-26-318408 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-27 | Rooney Terence Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 76,000 | 0 | — | 76,000 | Direct (D) | No | F2
| Open filing 0001193125-26-318408 Read from the filing’s XML Dispute this row |
| 2026-07-07 Filed 2026-07-07 | Mainolfi Nello Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 50,000 | 2.08 | 104,000Derived: shares × price per share. Exact value 104000.00. | 716,568 | Direct (D) | Yes | F1
| Open filing 0001193125-26-297817 Read from the filing’s XML Dispute this row |
| 2026-07-07 Filed 2026-07-07 | Mainolfi Nello Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 50,000 | 119 | 5,950,000Derived: shares × price per share. Exact value 5950000. | 666,568 | Direct (D) | Yes | F1
| Open filing 0001193125-26-297817 Read from the filing’s XML Dispute this row |
| 2026-07-07 Filed 2026-07-07 | Mainolfi Nello Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 45,559 | 0 | — | 90,000 | Direct (D) | Yes | F1, F2
| Open filing 0001193125-26-297817 Read from the filing’s XML Dispute this row |
| 2026-07-07 Filed 2026-07-07 | Mainolfi Nello Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 4,441 | 0 | — | 14,284 | Direct (D) | Yes | F1, F2
| Open filing 0001193125-26-297817 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | Mainolfi Nello Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 80,000 | 2.08 | 166,400Derived: shares × price per share. Exact value 166400.00. | 746,568 | Direct (D) | Yes | F1, F2
| Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | Mainolfi Nello Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,883 | 112.8046 | 212,411.0618Derived: shares × price per share. Exact value 212411.0618. | 744,685 | Direct (D) | Yes | F1, F3
| Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | Mainolfi Nello Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,626 | 113.9758 | 755,203.6508Derived: shares × price per share. Exact value 755203.6508. | 738,059 | Direct (D) | Yes | F1, F4
| Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | Mainolfi Nello Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 24,105 | 114.9555 | 2,771,002.3275Derived: shares × price per share. Exact value 2771002.3275. | 713,954 | Direct (D) | Yes | F1, F5
| Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | Mainolfi Nello Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 44,050 | 115.6883 | 5,096,069.615Derived: shares × price per share. Exact value 5096069.6150. | 669,904 | Direct (D) | Yes | F1, F6
| Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | Mainolfi Nello Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,336 | 116.559 | 388,840.824Derived: shares × price per share. Exact value 388840.824. | 666,568 | Direct (D) | Yes | F1, F7
| Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | Mainolfi Nello Director · Officer: Chief Executive Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 80,000 | 0 | — | 135,559 | Direct (D) | Yes | F1, F8
| Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | Goodman Noah Officer: Chief Business Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,389 | 114.29 | 387,328.81Derived: shares × price per share. Exact value 387328.81. | 47,179.438 | Direct (D) | Yes | F1, F2
| Open filing 0001193125-26-295089 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Jacobs Bruce N. Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 61,378 | 5.33 | 327,144.74Derived: shares × price per share. Exact value 327144.74. | 321,992 | Direct (D) | Yes | F1, F2
| Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Jacobs Bruce N. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,500 | 110.5397 | 165,809.55Derived: shares × price per share. Exact value 165809.5500. | 320,492 | Direct (D) | Yes | F1, F3
| Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Jacobs Bruce N. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,700 | 111.5671 | 189,664.07Derived: shares × price per share. Exact value 189664.0700. | 318,792 | Direct (D) | Yes | F1, F4
| Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Jacobs Bruce N. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,100 | 112.7881 | 124,066.91Derived: shares × price per share. Exact value 124066.9100. | 317,692 | Direct (D) | Yes | F1, F5
| Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Jacobs Bruce N. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,110 | 114.1875 | 469,310.625Derived: shares × price per share. Exact value 469310.6250. | 313,582 | Direct (D) | Yes | F1, F6
| Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Jacobs Bruce N. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 51,375 | 114.7696 | 5,896,288.2Derived: shares × price per share. Exact value 5896288.2000. | 262,207 | Direct (D) | Yes | F1, F7
| Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Jacobs Bruce N. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,971 | 115.8171 | 923,178.1041Derived: shares × price per share. Exact value 923178.1041. | 254,236 | Direct (D) | Yes | F1, F8
| Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Jacobs Bruce N. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,153 | 116.9937 | 719,862.2361Derived: shares × price per share. Exact value 719862.2361. | 248,083 | Direct (D) | Yes | F1, F9
| Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Jacobs Bruce N. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,200 | 117.7029 | 376,649.28Derived: shares × price per share. Exact value 376649.2800. | 244,883 | Direct (D) | Yes | F1, F10
| Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Jacobs Bruce N. Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 61,378 | 0 | — | 0 | Direct (D) | Yes | F1, F11
| Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,549 | 105.78 | 586,973.22Derived: shares × price per share. Exact value 586973.22. | 2,446,375 | Indirect (I) See footnote | Yes | F1, F2, F3, F4
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 14,798 | 106.63 | 1,577,910.74Derived: shares × price per share. Exact value 1577910.74. | 2,431,577 | Indirect (I) See footnote | Yes | F1, F2, F5, F4
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 19,419 | 107.76 | 2,092,591.44Derived: shares × price per share. Exact value 2092591.44. | 2,412,158 | Indirect (I) See footnote | Yes | F1, F2, F6, F4
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 10,848 | 108.28 | 1,174,621.44Derived: shares × price per share. Exact value 1174621.44. | 2,401,310 | Indirect (I) See footnote | Yes | F1, F2, F7, F4
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,968 | 109.75 | 874,488Derived: shares × price per share. Exact value 874488.00. | 2,393,342 | Indirect (I) See footnote | Yes | F1, F2, F8, F4
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,723 | 110.67 | 854,704.41Derived: shares × price per share. Exact value 854704.41. | 2,385,619 | Indirect (I) See footnote | Yes | F1, F2, F9, F4
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 934 | 111.20 | 103,860.8Derived: shares × price per share. Exact value 103860.80. | 2,384,685 | Indirect (I) See footnote | Yes | F1, F2, F10, F4
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 770 | 105.78 | 81,450.6Derived: shares × price per share. Exact value 81450.60. | 471,497 | Indirect (I) See footnote | Yes | F1, F2, F3, F11
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,133 | 106.63 | 227,441.79Derived: shares × price per share. Exact value 227441.79. | 469,364 | Indirect (I) See footnote | Yes | F1, F2, F5, F11
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,698 | 107.76 | 290,736.48Derived: shares × price per share. Exact value 290736.48. | 466,666 | Indirect (I) See footnote | Yes | F1, F2, F6, F11
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,498 | 108.28 | 162,203.44Derived: shares × price per share. Exact value 162203.44. | 465,168 | Indirect (I) See footnote | Yes | F1, F2, F7, F11
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,104 | 109.75 | 121,164Derived: shares × price per share. Exact value 121164.00. | 464,064 | Indirect (I) See footnote | Yes | F1, F2, F8, F11
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,078 | 110.67 | 119,302.26Derived: shares × price per share. Exact value 119302.26. | 462,986 | Indirect (I) See footnote | Yes | F1, F2, F9, F11
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-07-02 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 130 | 111.20 | 14,456Derived: shares × price per share. Exact value 14456.00. | 462,856 | Indirect (I) See footnote | Yes | F1, F2, F10, F11
| Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row |
| 2026-06-29 Filed 2026-06-30 | Booth Bruce Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 10,658 | 108.28 | 1,154,048.24Derived: shares × price per share. Exact value 1154048.24. | 2,402,089 | Indirect (I) See footnote | Yes | F1, F2, F3
| Open filing 0001451612-26-000020 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,793 filings read, the latest filed 2026-11-17. Prior quarter ending 2026-06-30: 9,164 filings read.
Showing 1–50 of 319
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| FMR LLC Partly reported under another manager | 12,568,921 SH | 1,405,079,714 dollars | Higher by 219,665 Prior quarter: 12,349,256 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager | 8,725,908 SH | 975,470 dollars | Higher by 1,612,928 Prior quarter: 7,112,980 | Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row |
| BAKER BROS. ADVISORS LP | 8,657,242 SH | 967,793,083 dollars | Unchanged Prior quarter: 8,657,242 | Open filing 0001104659-26-128308 Filed 2026-11-16 Dispute this row |
| Avoro Capital Advisors LLC | 7,474,747 SH | 835,601,967 dollars | Unchanged Prior quarter: 7,474,747 | Open filing 0001104659-26-127608 Filed 2026-11-16 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 5,825,416 SH | 651,223,250 dollars | Higher by 287,206 Prior quarter: 5,538,210 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| T. Rowe Price Investment Management, Inc. | 5,736,316 SH | 641,263 dollars | Lower by 520,945 Prior quarter: 6,257,261 | Open filing 0001897612-26-000766 Filed 2026-11-16 Dispute this row |
| BVF INC/IL Partly reported under another manager | 3,872,052 SH | 432,856,693 dollars | Unchanged Prior quarter: 3,872,052 | Open filing 0000921895-26-003162 Filed 2026-11-16 Dispute this row |
| WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager | 3,706,994 SH | 414,404,859 dollars | Higher by 31,966 Prior quarter: 3,675,028 | Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,044,214 SH | 340,312,683 dollars | Higher by 111,836 Prior quarter: 2,932,378 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2,978,521 SH | 332,968,863 dollars | Lower by 13,672 Prior quarter: 2,992,193 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| Atlas Venture Life Science Advisors, LLC | 2,847,541 SH | 318,326,608 dollars | Unchanged Prior quarter: 2,847,541 | Open filing 0001104659-26-125242 Filed 2026-11-10 Dispute this row |
| Siren, L.L.C. Partly reported under another manager | 2,784,898 SH | 311,323,747 dollars | Lower by 150,932 Prior quarter: 2,935,830 | Open filing 0002005245-26-000013 Filed 2026-11-12 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 2,582,973 SH | 288,750,552 dollars | Lower by 154,253 Prior quarter: 2,737,226 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 1,913,528 SH | 213,956,388 dollars | Higher by 97,197 Prior quarter: 1,816,331 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 1,208,462 SH | 135,093,968 dollars | Higher by 21,129 Prior quarter: 1,187,333 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| Capital Research Global Investors Partly reported under another manager | 1,130,378 SH | 126,364,957 dollars | Lower by 258,503 Prior quarter: 1,388,881 | Open filing 0001422848-26-000129 Filed 2026-11-12 Dispute this row |
| UBS Group AG Partly reported under another manager | 1,034,482 SH | 115,644,743 dollars | Higher by 26,705 Prior quarter: 1,007,777 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 886,951 SH | 99,152,252 dollars | Higher by 357,222 Prior quarter: 529,729 | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| ALLIANCEBERNSTEIN L.P. Partly reported under another manager | 819,071 SH | 91,563,947 dollars | Lower by 162,450 Prior quarter: 981,521 | Open filing 0001109448-26-000342 Filed 2026-11-16 Dispute this row |
| Driehaus Capital Management LLC | 808,098 SH | 90,337,275 dollars | Lower by 111,135 Prior quarter: 919,233 | Open filing 0000938206-26-000066 Filed 2026-11-16 Dispute this row |
| Merck Co., Inc. | 772,165 SH | 86,320,325 dollars | Unchanged Prior quarter: 772,165 | Open filing 0000310158-26-000249 Filed 2026-11-13 Dispute this row |
| FEDERATED HERMES, INC. Partly reported under another manager | 747,432 SH | 83,555,423 dollars | Lower by 1,966 Prior quarter: 749,398 | Open filing 0001623632-26-001675 Filed 2026-11-12 Dispute this row |
| Holocene Advisors, LP | 721,687 SH | 80,677,390 dollars | Higher by 85,108 Prior quarter: 636,579 | Open filing 0001172661-26-005338 Filed 2026-11-16 Dispute this row |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Partly reported under another manager | 702,329 SH | 78,513,362 dollars | Lower by 34,537 Prior quarter: 736,866 | Open filing 0000861177-26-000005 Filed 2026-11-16 Dispute this row |
| DIMENSIONAL FUND ADVISORS LP Partly reported under another manager | 693,290 SH | 77,496,888 dollars | Lower by 51,862 Prior quarter: 745,152 | Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row |
| Hood River Capital Management LLC | 637,295 SH | 71,243,208 dollars | Not in the prior quarter’s filings read | Open filing 0001214659-26-014212 Filed 2026-11-16 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 604,045 SH | 67,526,191 dollars | Higher by 22,138 Prior quarter: 581,907 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 564,133 SH | 63,064,428 dollars | Lower by 176,733 Prior quarter: 740,866 | Open filing 0001172661-26-005367 Filed 2026-11-16 Dispute this row |
| FRANKLIN TEMPLETON INC Partly reported under another manager | 552,284 SH | 75,248,696 dollars | Higher by 37,234 Prior quarter: 515,050 | Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row |
| Boxer Capital Management, LLC | 524,551 SH | 58,639,556 dollars | Higher by 95,451 Prior quarter: 429,100 | Open filing 0001213900-26-120704 Filed 2026-11-16 Dispute this row |
| JENNISON ASSOCIATES LLC Partly reported under another manager | 509,160 SH | 56,918,997 dollars | Higher by 6,182 Prior quarter: 502,978 | Open filing 0000053417-26-000068 Filed 2026-11-16 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 503,090 SH | 56,240,431 dollars | Higher by 53,359 Prior quarter: 449,731 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| Woodline Partners LP | 500,868 SH | 55,992,034 dollars | Unchanged Prior quarter: 500,868 | Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row |
| EVENTIDE ASSET MANAGEMENT, LLC | 490,611 SH | 54,843,362 dollars | Lower by 13,599 Prior quarter: 504,210 | Open filing 0001580642-26-007711 Filed 2026-11-13 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 474,764 SH | 53,073,867 dollars | Higher by 96,478 Prior quarter: 378,286 | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
| Rock Springs Capital Management LP | 409,631 SH | 45,792,649 dollars | Lower by 43,525 Prior quarter: 453,156 | Open filing 0001172661-26-005279 Filed 2026-11-16 Dispute this row |
| Clearbridge Investments, LLC | 396,827 SH | 44,361,290 dollars | Higher by 49,606 Prior quarter: 347,221 | Open filing 0001348883-26-000026 Filed 2026-11-12 Dispute this row |
| BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager | 382,804 SH | 42,793,659 dollars | Higher by 6,936 Prior quarter: 375,868 | Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 359,192 SH | 40,154,171 dollars | Higher by 164,349 Prior quarter: 194,843 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| Fisher Asset Management, LLC Partly reported under another manager | 323,219 SH | 36,132,651 dollars | Higher by 310,487 Prior quarter: 12,732 | Open filing 0000850529-26-000009 Filed 2026-11-06 Dispute this row |
| BRAIDWELL LP | 300,569 SH | 33,600,609 dollars | Lower by 77,594 Prior quarter: 378,163 | Open filing 0001420506-26-002894 Filed 2026-11-16 Dispute this row |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300,000 SH | 33,537,000 dollars | Higher by 100,000 Prior quarter: 200,000 | Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row |
| Pictet Asset Management Holding SA | 298,928 SH | 33,363,049 dollars | Lower by 96,612 Prior quarter: 395,540 | Open filing 0001993888-26-000007 Filed 2026-11-03 Dispute this row |
| VOYA INVESTMENT MANAGEMENT LLC Partly reported under another manager | 296,062 SH | 33,096,772 dollars | Higher by 26,148 Prior quarter: 269,914 | Open filing 0001068837-26-000006 Filed 2026-11-10 Dispute this row |
| Nextech Invest Ltd. | 278,896 SH | 31,177,784 dollars | Unchanged Prior quarter: 278,896 | Open filing 0001595430-26-000015 Filed 2026-11-16 Dispute this row |
| LORD, ABBETT CO. LLC | 246,777 SH | 27,587 dollars | Not in the prior quarter’s filings read | Open filing 0000930413-26-003314 Filed 2026-11-13 Dispute this row |
| RTW INVESTMENTS, LP | 240,000 SH | 26,829,600 dollars | Unchanged Prior quarter: 240,000 | Open filing 0001493215-26-000214 Filed 2026-11-16 Dispute this row |
| Connor, Clark Lunn Investment Management Ltd. | 233,521 SH | 26,105,313 dollars | Higher by 83,613 Prior quarter: 149,908 | Open filing 0001596800-26-000018 Filed 2026-11-10 Dispute this row |
| TD ASSET MANAGEMENT INC | 227,184 SH | 25,106,104 dollars | Lower by 45,716 Prior quarter: 272,900 | Open filing 0001193125-26-460060 Filed 2026-11-13 Dispute this row |
| Janus Henderson Group Ltd. Partly reported under another manager | 224,961 SH | 25,168,637 dollars | Not in the prior quarter’s filings read | Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- NORGES BANK 757,246 SH
- Sixth Street Partners Management Company, L.P. 529,729 SH
- BOONE CAPITAL MANAGEMENT LLC 113,173 SH
- CITADEL ADVISORS LLC 111,555 SH
- Burkehill Global Management, LP 75,000 SH
- NEW YORK STATE COMMON RETIREMENT FUND 28,780 SH
- SCHRODER INVESTMENT MANAGEMENT GROUP 27,997 SH
- SILVERARC CAPITAL MANAGEMENT, LLC 25,000 SH
- Freestone Grove Partners LP 21,176 SH
- Jupiter Topco LLC 21,058 SH
- Man Group plc 19,085 SH
- Jump Financial, LLC 13,803 SH
- Susquehanna Portfolio Strategies, LLC 13,768 SH
- Scientech Research LLC 12,943 SH
- Virtu Financial LLC 12,556 SH
- Jupiter Research Capital (Asia) Ltd 9,901 SH
- GSA CAPITAL PARTNERS LLP 7,343 SH
- Aster Capital Management (DIFC) Ltd 5,661 SH
- Blackstone Inc. 5,087 SH
- SG Americas Securities, LLC 4,674 SH
- ALGERT GLOBAL LLC 3,430 SH
- TWO SIGMA SECURITIES, LLC 2,716 SH
- DLD Asset Management, LP 2,500 SH
- Empowered Funds, LLC 2,338 SH
- Mitsubishi UFJ Trust Banking Corp 1,376 SH
- ACADIAN ASSET MANAGEMENT LLC 1,035 SH
- MERCER GLOBAL ADVISORS INC /ADV 916 SH
- SUMMIT SECURITIES GROUP LLC 750 SH
- Pacer Advisors, Inc. 589 SH
- Optiver Holding B.V. 297 SH
- Truvestments Capital LLC 104 SH
- AdvisorNet Financial, Inc 60 SH
- BERTHEL, FISHER COMPANY FINANCIAL SERVICES, INC. 16 SH
- Integrated Wealth Concepts LLC 15 SH
- FIDUCIARY FINANCIAL ADVISORS 14 SH
- Stone House Investment Management, LLC 5 SH
- HFM Investment Advisors, LLC 2 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| BlackRock, Inc. Common Stock | 6.6 | 5,450,286 | 09/30/2026 Filed 2026-10-27 | SCHEDULE 13G/AAmendment 4 | Open filing 0002012383-26-003919 Dispute this row |
| T. Rowe Price Associates, Inc. COMMON STOCK | 10.7 | 8,873,588 | 08/31/2026 Filed 2026-09-08 | SCHEDULE 13G/AAmendment 8 | Open filing 0000080255-26-000601 Dispute this row |
| T. Rowe Price Associates, Inc. COMMON STOCK | 8.6 | 7,112,345 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 7 | Open filing 0000080255-26-000572 Dispute this row |
| Atlas Venture Fund X, L.P. COMMON STOCK, $0.0001 PAR VALUE | 2.9 | 2,384,685.00 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 5 | Open filing 0001628098-26-000009 Dispute this row |
| ATLAS VENTURE ASSOCIATES X, L.P. COMMON STOCK, $0.0001 PAR VALUE | 2.9 | 2,384,685.00 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 5 | Open filing 0001628098-26-000009 Dispute this row |
| Atlas Venture Associates X, LLC COMMON STOCK, $0.0001 PAR VALUE | 2.9 | 2,384,685.00 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 5 | Open filing 0001628098-26-000009 Dispute this row |
| Atlas Venture Opportunity Fund I, L.P. COMMON STOCK, $0.0001 PAR VALUE | 0.6 | 462,856.00 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 5 | Open filing 0001628098-26-000009 Dispute this row |
| Atlas Venture Associates Opportunity I, L.P. COMMON STOCK, $0.0001 PAR VALUE | 0.6 | 462,856.00 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 5 | Open filing 0001628098-26-000009 Dispute this row |
| Atlas Venture Associates Opportunity I, LLC COMMON STOCK, $0.0001 PAR VALUE | 0.6 | 462,856.00 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 5 | Open filing 0001628098-26-000009 Dispute this row |
| BIOTECHNOLOGY VALUE FUND L P Common Stock, $0.0001 par value per share | 3.3 | 2,712,852.00 | 06/26/2026 Filed 2026-06-26 | SCHEDULE 13D/AAmendment 6 | Open filing 0000921895-26-001687 Dispute this row |
| BVF I GP LLC Common Stock, $0.0001 par value per share | 3.3 | 2,712,852.00 | 06/26/2026 Filed 2026-06-26 | SCHEDULE 13D/AAmendment 6 | Open filing 0000921895-26-001687 Dispute this row |
| BIOTECHNOLOGY VALUE FUND II LP Common Stock, $0.0001 par value per share | 2.6 | 2,124,859.00 | 06/26/2026 Filed 2026-06-26 | SCHEDULE 13D/AAmendment 6 | Open filing 0000921895-26-001687 Dispute this row |
| BVF II GP LLC Common Stock, $0.0001 par value per share | 2.6 | 2,124,859.00 | 06/26/2026 Filed 2026-06-26 | SCHEDULE 13D/AAmendment 6 | Open filing 0000921895-26-001687 Dispute this row |
| Biotechnology Value Trading Fund OS LP Common Stock, $0.0001 par value per share | 0.4 | 292,856.00 | 06/26/2026 Filed 2026-06-26 | SCHEDULE 13D/AAmendment 6 | Open filing 0000921895-26-001687 Dispute this row |
| BVF Partners OS Ltd. Common Stock, $0.0001 par value per share | 0.4 | 292,856.00 | 06/26/2026 Filed 2026-06-26 | SCHEDULE 13D/AAmendment 6 | Open filing 0000921895-26-001687 Dispute this row |
| BVF GP HOLDINGS LLC Common Stock, $0.0001 par value per share | 5.8 | 4,837,711.00 | 06/26/2026 Filed 2026-06-26 | SCHEDULE 13D/AAmendment 6 | Open filing 0000921895-26-001687 Dispute this row |
| BVF PARTNERS L P/IL Common Stock, $0.0001 par value per share | 6.3 | 5,237,151.00 | 06/26/2026 Filed 2026-06-26 | SCHEDULE 13D/AAmendment 6 | Open filing 0000921895-26-001687 Dispute this row |
| BVF INC/IL Common Stock, $0.0001 par value per share | 6.3 | 5,237,151.00 | 06/26/2026 Filed 2026-06-26 | SCHEDULE 13D/AAmendment 6 | Open filing 0000921895-26-001687 Dispute this row |
| LAMPERT MARK N Common Stock, $0.0001 par value per share | 6.3 | 5,237,151.00 | 06/26/2026 Filed 2026-06-26 | SCHEDULE 13D/AAmendment 6 | Open filing 0000921895-26-001687 Dispute this row |
| Hrustanovic Gorjan Common Stock, $0.0001 par value per share | 0.1 | 116,190.00 | 06/26/2026 Filed 2026-06-26 | SCHEDULE 13D/AAmendment 6 | Open filing 0000921895-26-001687 Dispute this row |
| T. Rowe Price Investment Management, Inc. COMMON STOCK | 6.7 | 5,460,257 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G | Open filing 0001897612-26-000493 Dispute this row |
| Wellington Management Group LLP Common Stock | 4.8 | 3,889,687.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 8 | Open filing 0000902219-26-000204 Dispute this row |
| Wellington Group Holdings LLP Common Stock | 4.8 | 3,889,687.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 8 | Open filing 0000902219-26-000204 Dispute this row |
| Wellington Investment Advisors Holdings LLP Common Stock | 4.8 | 3,889,687.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 8 | Open filing 0000902219-26-000204 Dispute this row |
| FMR LLC COMMON STOCK | 14.3 | 11,681,450.45 | 03/31/2026 Filed 2026-05-06 | SCHEDULE 13G/AAmendment 4 | Open filing 0000315066-26-001229 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 14.3 | 11,681,450.45 | 03/31/2026 Filed 2026-05-06 | SCHEDULE 13G/AAmendment 4 | Open filing 0000315066-26-001229 Dispute this row |
| The Vanguard Group Common Stock | 0 | 0 | 03/13/2026 Filed 2026-03-27 | SCHEDULE 13G/AAmendment 4 | Open filing 0000102909-26-001649 Dispute this row |
| Wellington Management Group LLP Common Stock | 5.5 | 4,412,933.00 | 12/31/2025 Filed 2026-02-10 | SCHEDULE 13G/AAmendment 7 | Open filing 0000902219-26-000017 Dispute this row |
| Wellington Group Holdings LLP Common Stock | 5.5 | 4,412,933.00 | 12/31/2025 Filed 2026-02-10 | SCHEDULE 13G/AAmendment 7 | Open filing 0000902219-26-000017 Dispute this row |
| Wellington Investment Advisors Holdings LLP Common Stock | 5.5 | 4,412,933.00 | 12/31/2025 Filed 2026-02-10 | SCHEDULE 13G/AAmendment 7 | Open filing 0000902219-26-000017 Dispute this row |
| Wellington Management Company LLP Common Stock | 5.3 | 4,412,933.00 | 12/31/2025 Filed 2026-02-10 | SCHEDULE 13G/AAmendment 7 | Open filing 0000902219-26-000017 Dispute this row |
| FMR LLC COMMON STOCK | 11.2 | 8,928,574.12 | 12/31/2025 Filed 2026-01-08 | SCHEDULE 13G/AAmendment 3 | Open filing 0000315066-26-000053 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 11.2 | 8,928,574.12 | 12/31/2025 Filed 2026-01-08 | SCHEDULE 13G/AAmendment 3 | Open filing 0000315066-26-000053 Dispute this row |
| BIOTECHNOLOGY VALUE FUND L P Common Stock, $0.0001 par value per share | 4.4 | 3,550,766.00 | 12/11/2025 Filed 2025-12-15 | SCHEDULE 13D/AAmendment 5 | Open filing 0000921895-25-003346 Dispute this row |
| BVF I GP LLC Common Stock, $0.0001 par value per share | 4.4 | 3,550,766.00 | 12/11/2025 Filed 2025-12-15 | SCHEDULE 13D/AAmendment 5 | Open filing 0000921895-25-003346 Dispute this row |
| BIOTECHNOLOGY VALUE FUND II LP Common Stock, $0.0001 par value per share | 3.4 | 2,752,456.00 | 12/11/2025 Filed 2025-12-15 | SCHEDULE 13D/AAmendment 5 | Open filing 0000921895-25-003346 Dispute this row |
| BVF II GP LLC Common Stock, $0.0001 par value per share | 3.4 | 2,752,456.00 | 12/11/2025 Filed 2025-12-15 | SCHEDULE 13D/AAmendment 5 | Open filing 0000921895-25-003346 Dispute this row |
| Biotechnology Value Trading Fund OS LP Common Stock, $0.0001 par value per share | 0.5 | 406,145.00 | 12/11/2025 Filed 2025-12-15 | SCHEDULE 13D/AAmendment 5 | Open filing 0000921895-25-003346 Dispute this row |
| BVF Partners OS Ltd. Common Stock, $0.0001 par value per share | 0.5 | 406,145.00 | 12/11/2025 Filed 2025-12-15 | SCHEDULE 13D/AAmendment 5 | Open filing 0000921895-25-003346 Dispute this row |
| BVF GP HOLDINGS LLC Common Stock, $0.0001 par value per share | 7.8 | 6,303,222.00 | 12/11/2025 Filed 2025-12-15 | SCHEDULE 13D/AAmendment 5 | Open filing 0000921895-25-003346 Dispute this row |
| BVF PARTNERS L P/IL Common Stock, $0.0001 par value per share | 8.5 | 6,867,809.00 | 12/11/2025 Filed 2025-12-15 | SCHEDULE 13D/AAmendment 5 | Open filing 0000921895-25-003346 Dispute this row |
| BVF INC/IL Common Stock, $0.0001 par value per share | 8.5 | 6,867,809.00 | 12/11/2025 Filed 2025-12-15 | SCHEDULE 13D/AAmendment 5 | Open filing 0000921895-25-003346 Dispute this row |
| LAMPERT MARK N Common Stock, $0.0001 par value per share | 8.5 | 6,867,809.00 | 12/11/2025 Filed 2025-12-15 | SCHEDULE 13D/AAmendment 5 | Open filing 0000921895-25-003346 Dispute this row |
| Hrustanovic Gorjan Common Stock, $0.0001 par value per share | 0.1 | 100,190.00 | 12/11/2025 Filed 2025-12-15 | SCHEDULE 13D/AAmendment 5 | Open filing 0000921895-25-003346 Dispute this row |
| Baker Bros. Advisors LP Common Stock, $0.0001 par value per share | 10.9 | 8,676,797.00 | 12/09/2025 Filed 2025-12-11 | SCHEDULE 13D/AAmendment 3 | Open filing 0001104659-25-120356 Dispute this row |
| Baker Bros. Advisors (GP) LLC Common Stock, $0.0001 par value per share | 10.9 | 8,676,797.00 | 12/09/2025 Filed 2025-12-11 | SCHEDULE 13D/AAmendment 3 | Open filing 0001104659-25-120356 Dispute this row |
| Julian C. Baker Common Stock, $0.0001 par value per share | 10.9 | 8,676,797.00 | 12/09/2025 Filed 2025-12-11 | SCHEDULE 13D/AAmendment 3 | Open filing 0001104659-25-120356 Dispute this row |
| Felix J. Baker Common Stock, $0.0001 par value per share | 10.9 | 8,676,797.00 | 12/09/2025 Filed 2025-12-11 | SCHEDULE 13D/AAmendment 3 | Open filing 0001104659-25-120356 Dispute this row |
| T. Rowe Price Associates, Inc. COMMON STOCK | 7.1 | 5,097,704 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 6 | Open filing 0000080255-25-000835 Dispute this row |
| FMR LLC COMMON STOCK | 8.2 | 5,879,611.12 | 09/30/2025 Filed 2025-11-05 | SCHEDULE 13G/AAmendment 2 | Open filing 0000315066-25-002767 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,312,501 filings read, dated 2004-06-14 to 2026-11-17: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 17,836 |
| 2016 | 207,737 |
| 2017 | 207,865 |
| 2018 | 202,770 |
| 2019 | 215,153 |
| 2020 | 144,184 |
| 2021 | 224,474 |
| 2022 | 158,941 |
| 2023 | 199,811 |
| 2024 | 209,823 |
| 2025 | 235,520 |
| 2026 | 260,174 |
Filings made before the SEC required XML are listed, not extracted.